Quarterly report pursuant to Section 13 or 15(d)

Revenue from Contracts with Customers (Tables)

v3.24.1.u1
Revenue from Contracts with Customers (Tables)
6 Months Ended
Mar. 31, 2024
Revenue from Contracts with Customers [Abstract]  
Revenue from Customers by Products

Three Months Ended

Six Months Ended

March 31,

March 31,

2024

2023

2024

2023

FC2

Global public health sector

$

3,537,994

$

2,434,287

$

5,045,001

$

4,771,284

U.S. prescription channel

597,307

4,146,160

1,231,026

4,309,164

Total FC2

4,135,301

6,580,447

6,276,027

9,080,448

ENTADFI

5,520

13,313

Net revenues

$

4,135,301

$

6,585,967

$

6,276,027

$

9,093,761

Revenue by Geographic Area

Three Months Ended

Six Months Ended

March 31,

March 31,

2024

2023

2024

2023

United States

$

1,237,629

$

4,787,258

$

2,593,718

$

5,596,635

South Africa

1,177,200

1,328,400

1,177,200

1,329,678

Mozambique

855,360

*

855,360

*

Other

865,112

470,309

1,649,749

2,167,448

Net revenues

$

4,135,301

$

6,585,967

$

6,276,027

$

9,093,761

*Less than 10% of total net revenues